Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Supply Reagents for Solexa's Genome Analyzer

NEW YORK (GenomeWeb News) - Invitrogen and Solexa have signed an OEM agreement in which Invitrogen will supply reagents for Solexa's soon-to-be-released sequencing technology, the companies said today.
Specifically, Invitrogen will supply most of the reagents for Solexa's sequencing, gene expression, and small RNA analysis kits, which will be used with the Solexa Genome Analysis System, the companies said.
Financial terms of the agreement were not disclosed.
In a statement today, Solexa said it is currently taking orders for the new system and expects to begin broadly shipping the platform this fall.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.